<DOC>
	<DOCNO>NCT01576094</DOCNO>
	<brief_summary>Congenital heart defect prevalent group congenital malformation newborn . Surgery-related low cardiac output syndrome ( LCOS ) could one reason unfavourable outcome population . The early use inodilators ( INDs ) , specifically milrinone ( MR ) , propose reduce afterload increase inotropism . Studies paediatric population appear support clinical usefulness MR similar observe adult . Levosimendan ( LEVO ) novel class IND develop treatment heart failure . Experience LEVO paediatric patient scarce . The purpose study systematically test efficacy safety milrinone ( MR ) levosimendan ( LEVO ) newborns undergoing cardiovascular surgery cardiopulmonary bypass ( CPB ) . Given uncertainty LEVO pharmacokinetics neonate , study design pilot , phase I feasibility study .</brief_summary>
	<brief_title>Two Inodilators Postsurgery Neonates</brief_title>
	<detailed_description>Surgical repair primary therapy congenital heart defect newborn . The neonatal cardiovascular system particular risk develop surgery-related low cardiac output syndrome ( LCOS ) , thus vasoactive agent routinely use postoperative management . Systematic research efficacy drug scarce newborn . As LCOS pathophysiology joint impaired myocardial contractility peripheral effect ischemia/reperfusion injury endothelium , early use inodilators ( IND ) strongly recommend reduce afterload improve contractility . This study aim test equivalence dose-dependent hemodynamic effect 2 IND , Milrinone Levosimendan , use early without load dose preoperative period prevent LCOS . By mean non-invasive technology investigator assess cardiac function ( serial structural functional echocardiography ) , cerebral peripheral perfusion oxygenation ( continuous near-infrared monitoring ) , cerebral function ( continuous amplitude integrate EEG monitoring ) , rule CNS acquire lesion ( serial transfontanelar echo-Doppler study ) , follow different biochemical marker myocardial stress apoptosis . Pharmacokinetic study also perform .</detailed_description>
	<mesh_term>Cardiac Output , Low</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<mesh_term>Milrinone</mesh_term>
	<criteria>Newborns undergo cardiovascular surgery stable preoperative haemodynamic condition Parental consent give Parental consent refuse Inodilators contraindicate</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>40 Days</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>congenital heart disease</keyword>
</DOC>